Haiyan Zhou
Overview
Explore the profile of Haiyan Zhou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
408
Citations
4138
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhou H, Yan X, Song Y, Yang X, Chen X, Huang Y
Foods
. 2025 Mar;
14(5).
PMID: 40077500
Fluoroquinolones (FQs) are present in trace amounts in the environment, from where they enter animal- and plant-derived food products. Long-term exposure to low-dose drugs poses a risk to human health...
2.
Ji W, Xie X, Bai G, Fan Y, He Y, Zhang L, et al.
J Proteome Res
. 2025 Feb;
24(3):1449-1461.
PMID: 39979118
Vitamin D (VD) levels are closely related to the occurrence of post-COVID-19 conditions (PCCs), but the specific mechanism is still unclear. Here, a total of 50 PCC patient serum samples...
3.
Liu Y, Zhou R, Guo Y, Hu B, Xie L, An Y, et al.
Cell Metab
. 2025 Jan;
PMID: 39879982
The benefits of exercise for metabolic health occur in a dose-dependent manner. However, the adverse effects of overtraining and their underlying mechanisms remain unclear. Here, we show that overtraining induces...
4.
Zhang X, Xu Z, Yao Y, Zheng H, Wu J, Hu J, et al.
Hypertension
. 2025 Jan;
82(3):532-541.
PMID: 39807594
Background: Although the information on the validation status of electronic sphygmomanometer (ES) devices in use in health care institutions and households is much more clinically relevant than that of ES...
5.
Liu D, Li Q, Yan S, Zhang X, Li W, Wang F, et al.
Cancer Chemother Pharmacol
. 2025 Jan;
95(1):19.
PMID: 39776242
Purpose: PLB1004, developed by Beijing Avistone Biotechnology Co., Ltd., is a safe, highly selective, and efficient irreversible epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) employed in treating non-small-cell-lung-cancer (NSCLC)....
6.
Qi Y, Xu B, He J, Jiang B, Yan L, Zhou H, et al.
Drug Des Devel Ther
. 2025 Jan;
18:6263-6281.
PMID: 39741917
Purpose: Triple-negative breast cancer (TNBC) is a disease associated with high incidence and high mortality, which is a major problem threatening women's health. Xiaoyao Sanjie Decoction (XYSJD) exhibits remarkable therapeutic...
7.
Chen Q, Lin H, Zheng C, Mudrik E, Kashentseva T, Cheng Y, et al.
Mol Ecol
. 2024 Dec;
34(2):e17606.
PMID: 39688010
To ensure the success of genetic rescue, we must minimise the potential negative effects of outbreeding depression that may arise from selecting source populations. The difficulty in assessing the likelihood...
8.
Brambilla L, Valori C, Guidotti G, Martorana F, Sulmona C, De Martini L, et al.
Transl Neurodegener
. 2024 Dec;
13(1):63.
PMID: 39681882
No abstract available.
9.
Zong L, Zhou H, Zhao X
J Musculoskelet Neuronal Interact
. 2024 Dec;
24(4):394-399.
PMID: 39616509
Objective: To analyze the incidence and influencing factors of perioperative occult blood loss in elderly hip fracture patients. Methods: 145 cases of elderly hip fracture patients treated at our hospital...
10.
Zhou H, Hu Z, Cai X, Liu Z, Jin L, Zheng Y
Sheng Wu Gong Cheng Xue Bao
. 2024 Nov;
40(11):4288-4300.
PMID: 39584352
The Principle of Biotechnology is a compulsory course for undergraduates majoring in bioengineering at Zhejiang University of Technology. In response to the "Double First-Class" initiative and in order to improve...